Conference item icon

Conference item

PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author


Host title:
INFLAMMATORY BOWEL DISEASES
Volume:
15
Issue:
12
Pages:
S11-S11
Publication date:
2009-12-01
ISSN:
1078-0998


Pubs id:
pubs:66784
UUID:
uuid:0ede6e1b-bdf1-4abd-8156-aade05ae0d77
Local pid:
pubs:66784
Source identifiers:
66784
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP